Ipsophene:
L'Avenir du Paracétamol Français
A modern corporate vision for health sovereignty. We combine rigorous pharmaceutical engineering with premium innovation to produce the active principle of paracetamol entirely in France.
100% French
Complete supply chain sovereignty, securing national health needs through local production in Toulouse.
Continuous Flow
Innovative manufacturing processes ensuring higher purity, efficiency, and reliability compared to traditional batch methods.
Waste Reduction
A paradigm shift in ecological pharmaceutical manufacturing, dramatically reducing solvent use and environmental footprint.
Pure. Precise. Sovereign.
Our primary mission is the synthesis of paracetamol API (Active Pharmaceutical Ingredient). By mastering the complete molecular journey, we ensure unparalleled quality and reduce reliance on fragile global supply chains.
- arrow_forward Rigorous quality control at every synthesis stage.
- arrow_forward Designed for direct integration by national pharmaceutical laboratories.
- arrow_forward Meeting and exceeding the highest European pharmacopoeia standards.
A Green Pharmaceutical Future
Innovation is meaningless without responsibility. Ipsophene's infrastructure is designed from the ground up to minimize ecological impact, setting a new benchmark for industrial chemical production.
Latest Developments
Foundation Stone Laid in Toulouse
Official ceremony marking the beginning of construction for Europe's most advanced paracetamol production facility.
Breakthrough in Continuous Flow Synthesis
R&D team successfully demonstrates a 40% efficiency increase in the primary synthesis stage using new continuous flow reactors.
New Environmental Benchmarks Achieved
Independent audit confirms Ipsophene's pilot plant exceeds European environmental targets for solvent recovery.